​

Our latest research initiative focuses on using the power of whole genome sequencing (WGS) to address the burden of healthcare-associated infections (HAIs). By undertaking a research project, you have the opportunity to contribute to the future of infection prevention and control science.

​

    Why Participate:

​​

• Engage with our state-of-the-art technology, IDEM.

• Work alongside experts in bacterial genomics.

• Play a crucial role in advancing the global effort to combat HAIs.

 

The Programme

 

The primary objective of this project is to use whole genome sequencing to understand the genetic relationships between significant healthcare-associated bacterial pathogens.

 

Eligibility criteria:

 

1. Available to start a 3-6 month project starting between July 2024 and September 2024

2. Use or have access to an Illumina platform to sequence between 50 and 200 bacterial isolates​

 

How to Join:

Signing up is easy. Submit your application and we will email you back and organise an introduction call to discuss the Genpax Clinical Research Programme .

​

​

​